Pharmacology, Toxicology and Pharmaceutical Science
Myeloproliferative Neoplasm
100%
Case-Control Study
100%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
50%
Metformin
50%
Statin (Protein)
30%
Malignant Neoplasm
26%
Population Study
10%
Anticarcinogen
5%
Dose-Response Relationship
5%
Neoplasm
5%
Biochemistry, Genetics and Molecular Biology
Case-Control Study
100%
Statin
50%
Medical Record
50%
Population Research
30%
Hemoglobin Blood Level
25%
Erythropoiesis-Stimulating Agent
25%
Population
25%
Dose Response
25%
Myeloid
5%
Population Dynamics
5%
Medicine and Dentistry
Patient Characteristics
50%
Myelodysplastic Syndrome
50%
Myeloproliferative Neoplasm
50%
Case-Control Study
50%
Glycon
50%
Odds Ratio
22%
Malignant Neoplasm
11%
Medical Record
9%
Dose Response
5%
Anticarcinogen
5%
Treatment Duration
5%
Population Research
5%
Population
5%
